GL1X · GenesisL1 explorer

MolNFT v1 · #135785 · protein

Discovery of a potent btk inhibitor with a novel binding mode using parallel selections with a DNA-encoded chemical library

5U9D · Tyrosine-protein kinase btk: “Discovery of a potent btk inhibitor with a novel binding mode using parallel selections with a DNA-encoded…”. X-ray diffraction, 1 ligand (83P), 4 pockets (best druggability 0.72). MolNFT v1 #135785 on…

PDB
5U9D
Type
protein
Length
271 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase btk
EC
2.7.10.2
UniProt
Q06187
Ligands
83P
Pockets
4 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase btk (EC 2.7.10.2)protein27142% helix, 17% strandQ06187

Ligands and binding sites

  • 83P · (R)-N-methyl-2-(3-((quinoxalin-6-ylamino)methyl)furan-2-carbonyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxamide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A
  • PEG · Di(hydroxyethyl)ether · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1570.720.9816empty
23510.620.784683P
3920.610.8825empty
41090.400.7618EDO

Compared structures

  • 5U9D · Discovery of a potent BTK inhibitor with a novel binding mode using parallel selections… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q06187 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase btk (Q06187) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.